Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction

Heart Failure

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

Diabetes Res Clin Pract

Kokura Y, Kishimori T, Kato T, Iwasaki Y, Wada A, Tani A, Yamaji R, Koike J, Matsumoto T, Yagi T, Sekine O, Okada M

doi: 10.1016/j.diabres.2026.113404

Heart Failure

Secondary Mitral Regurgitation Trajectories and Prognosis With Intensification of Guideline-Directed Medical Therapy in Heart Failure

JACC Heart Fail

Ferrero C, Codina P, Lupón J, Ruiz-Cueto M, Zamora E, Borrellas A, Llibre C, Badia-Molins C, Prencipe A, Santiago-Vacas E, Domingo M, Santesmases J, Ferrer-Sistach E, Escabia C, Núñez J, Anker SD, Metra M, Butler J, Stone GW, Delgado V, Bayes-Genis A

doi: 10.1016/j.jchf.2026.103001

Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Eur J Heart Fail

Malgie J, Wilde MI, Koudstaal S, Denham R, da Fonseca CA, Swart HP, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, de Boer RA, Brunner-La Rocca HP, Brugts JJ

doi: 10.1002/ejhf.70006

Heart FailureTherapy and Intervention

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

JACC Cardiovasc Interv

Kobari Y, Maznyczka A, Khokhar AA, Sørensen LM, Lulic D, Bieliauskas G, Raja AA, Ersbøll MK, Rossing K, Gustafsson F, Køber L, Prendergast B, Fosbøl E, De Backer O

doi: 10.1016/j.jcin.2025.10.050

Heart Failure

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study

J Am Heart Assoc

Greene SJ, Adam A, Schmedt N, Carlsen C, Brand M, Davies E, Jouaville Abrouk LS, Prochaska JH, Tran P, Alhamdow A

doi: 10.1161/JAHA.125.044785

Heart Failure

Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey

Eur J Heart Fail

Seferović PM, Polovina M, Krejči J, Merkely B, Tokmakova M, Huelssmann M, Miloradović V, Apostolović S, Srbinovska-Kostovska E, Radovanović S, Stojšić-Milosavljević A, Milovančev A, Zdravković M, Glavaš D, Preradović-Kovačević T, Goncalvesova E, Laufer-Perl M, Marković-Nikolić N, Kušljugić Z, Hudić-Dizdarević L, Gaita D, Kamzola G, Sepp R, Simić D, Ristić A, Ašanin M, Krljanac G, Otašević P, Stanisavljević D, Miličić D, Abdelhamid M, Savarese G, Central/Eastern Europe QCC Survey Young Investigators

doi: 10.1002/ejhf.70031

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Heart Failure

Heart Failure Guideline-Directed Medical Therapy Scoring Systems: A Scoping Review

Circ Heart Fail

Dwivedi A, Cox Z, Hawkins NM, Moghaddam N, Sidsworth M, Virani S, Lee DS, Turgeon RD

doi: 10.1161/CIRCHEARTFAILURE.125.013881

Heart, Artery and Coronary Diseases

Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair

Eur J Heart Fail

Yoshida A, Yamamoto M, Nakazawa G, Mizutani K, Yamada N, Soejima N, Kawamura T, Matsuzoe H, Miyoshi T, Saji M, Kubo S, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Otsuki H, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Hachinohe D, Izumi Y, Shimura T, Sugiura A, Otsuka T, Hayashida K

doi: 10.1093/ejhf/xuag005

Related content

Impact of glucagon-like peptide-1 receptor agonists with guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and type 2 diabetes

Secondary Mitral Regurgitation Trajectories and Prognosis With Intensification of Guideline-Directed Medical Therapy in Heart Failure

Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF

Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction

Contemporary Guideline-Directed Medical Therapy for Heart Failure in the United States: The EMPACE Study

Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

Heart Failure Guideline-Directed Medical Therapy Scoring Systems: A Scoping Review

Clinical impact of early changes in guideline-directed medical therapy after mitral valve transcatheter edge-to-edge repair